ID: 56409 I Jan 2019 I Global I 209 pages I Precision Business Insights
Market Outline: Urothelial Carcinoma Treatment Market Urothelial carcinoma is also called as transitional cell carcinoma. Urothelial carcinoma is a type of cancer that occurs in the urinary system and it is most common type of bladder cancer of the ureter, urachus and urethra. Urothelial cell carcinoma starts from transitional epithelium. Potential signs in recognising the urothelial carcinoma include blood in urine, persistent back pain and painful urination. Generally, urothelial cell carcinoma is diagnosed using the blood tests and scanning. Treatment may include anticancer drugs, antibacterials to reduce or stop the growth of cancer cells and other treatments such as radiotherapy or nephroureterectomy are indicated. Market Dynamics: Urothelial Carcinoma Treatment Market Urothelial carcinoma treatment market is driven by the increase in global prevalence of the bladder cancer and emergence of potential diagnostics for identifying bladder cancer. Furthermore, increase funding for R&D; activities to develop new cancer therapies and growing awareness regarding early diagnosis of cancer as a result of awareness programs or other initiatives by government and non-government organizations are expected to boost the urothelial carcinoma treatment market over the forecast period. However, high cost of R&D; for development of new drugs and presence of generic drugs in the market are expected to hamper the market revenue growth during the forecast period. Market Scope: Urothelial Carcinoma Treatment Market Global urothelial carcinoma treatment market is segmented based on type of treatment, and distribution channel Based on treatment, it segmented into Immunotherapy Radiotherapy Chemotherapy Others Based on distribution channel, it is segmented into Hospital Pharmacies Retail Pharmacies Others Market Summary: Urothelial Carcinoma Treatment Market Global urothelial carcinoma treatment market growth is driven by increase in global prevalence rate of bladder cancer. According to World Cancer Research Fund International, bladder cancer is the ninth most common cancer in the world and in the year 2012 - 430,000 new cases were diagnosed. The market has many large players and actively developing and launching of new products related to urothelial carcinoma treatment. For instance, in March 2018, Bavarian Nordic A/S collaborated with F.Hoffmann-La Roche Ltd to evaluate the Tecentriq and CV301 drugs in urothelial cancer treatment. Furthermore, promising pipeline drugs for treatment of urothelial carcinoma such as B-701 (in phase 2 clinical trials by BioClin Therapeutics, FGFR-3 Antibody (By Eli Lilly and Company in phase 1 clinical trials) are expected to boost future revenue forecasts. Region Analysis: Urothelial Carcinoma Treatment Market Geographically, urothelial carcinoma treatment market has been segmented into Latin America, Europe, Asia- Pacific, North America, and the Middle East & Africa. North America expected to grow at significant rates owing to growing prevalence of bladder cancer, increase in awareness and well-established healthcare infrastructure. American Cancer Society estimates that, about 79,030 new cases of bladder cancer in 2018 in U.S. alone. Europe region expected to grow at notable rates owing to the factors such as growing awareness related to early diagnosis of cancer and developed healthcare infrastructure coupled with prevalence rates of urothelial cancer. Asia Pacific region is expected exhibit significant growth opportunity owing to developing healthcare infrastructure and low R&D; costs. Market Participants: Urothelial Carcinoma Treatment Market Some of the players in Market are GlaxoSmithKline plc (U.K.), Genentech, Inc. (U.S.), Novartis AG (Switzerland), Dendreon (U.S.), Merck KGaA (Germany), Eisai Co. (Japan), Sanofi S.A. (France), and Bristol-Myers Squibb (U.S.) to name a few Notable Market Developments: Urothelial carcinoma Treatment Market In May 2018, U.S. Food and Drug Administration approved Sereno Inc.’s (E. Merck KG) BAVENCIO (avelumab) for the treatment of urothelial carcinoma. In February 2018, U.S. FDA has approved Bristol-Mayer Squibb Company’s OPDIVO (Nivolumab) for the treatment of urothelial carcinoma.
1. Executive summary 2. Global Urothelial Carcinoma Treatment Market Introduction 2.1. Global Urothelial Carcinoma Treatment Market – Taxonomy 2.2. Global Urothelial Carcinoma Treatment Market –Definitions 2.2.1. Therapy 2.2.2. Distribution Channel 3. Global Urothelial Carcinoma Treatment Market Dynamics 3.1. Drivers 3.2. Restraints 3.3. Opportunities/Unmet Needs of the Market 3.4. Trends 3.5. Global Urothelial Carcinoma Treatment Market Dynamics – Factors Impact Analysis 3.6. Global Urothelial Carcinoma Treatment Market – Regulations 3.6.1. U.S 3.6.2. Europe 3.6.3. Japan 3.6.4. China 3.7. Global Urothelial Carcinoma Treatment Market – Product Innovations 4. Global Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 – 2025 4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) 4.3. Market Oppurtunity Analysis 5. Global Urothelial Carcinoma Treatment Market, By Therapy, 2014 - 2018 and Forecast, 2019 - 2025 5.1. Therapy Analysis (2014-2018) and Forecast (2019-2025) by Revenue (USD Mn) and Y-o-Y Growth (%) 5.1.1. Immunotherapy 5.1.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.1.1.3. Market Opportunity Analysis 5.1.2. Radiotherapy 5.1.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.1.2.3. Market Opportunity Analysis 5.1.3. Chemotherapy 5.1.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.1.3.3. Market Opportunity Analysis 5.1.4. Others 5.1.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 5.1.4.3. Market Opportunity Analysis 6. Market Opportunity Analysis Global Urothelial Carcinoma Treatment Market Forecast, By Distribution Channel, 2014 - 2018 and Forecast, 2019 - 2025 6.1. Hospital Pharmacies 6.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.1.3. Market Opportunity Analysis 6.2. Retail Pharmacies 6.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.2.3. Market Opportunity Analysis 6.3. Others 6.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 6.3.3. Market Opportunity Analysis 7. Global Urothelial Carcinoma Treatment Market Forecast, By Region, 2014 - 2018 and Forecast, 2019 - 2025 7.1. North America 7.1.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.1.3. Market Opportunity Analysis 7.2. Europe 7.2.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.2.3. Market Opportunity Analysis 7.3. Asia-Pacific 7.3.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.3.3. Market Opportunity Analysis 7.4. Latin America 7.4.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.4.3. Market Opportunity Analysis 7.5. Middle East and Africa 7.5.1. Market Analysis, 2014 – 2018 and Forecast, 2019 – 2025 (Revenue, USD Mn) 7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis 7.5.3. Market Opportunity Analysis 7.6. Global Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel, and Region, 2019 – 2025 8. North America Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 8.1.1. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 8.1.2. Immunotherapy 8.1.3. Radiotherapy 8.1.4. Chemotherapy 8.1.5. Others 8.1.6. Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 8.1.6.1. Hospital Pharmacies 8.1.6.2. Retail Pharmacies 8.1.6.3. Others 8.1.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) 8.1.7.1. U.S. 8.1.7.2. Canada 8.1.8. North America Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel and Country, 2019 – 2025 8.1.9. North America Urothelial Carcinoma Treatment Market Dynamics – Trends 9. Europe Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 9.1.1. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 9.1.2. Immunotherapy 9.1.3. Radiotherapy 9.1.4. Chemotherapy 9.1.5. Others 9.1.6. Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.1.6.1. Hospital Pharmacies 9.1.6.2. Retail Pharmacies 9.1.6.3. Others 9.1.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 9.1.7.1. Germany 9.1.7.2. UK 9.1.7.3. France 9.1.7.4. Spain 9.1.7.5. Italy 9.1.7.6. Russia 9.1.7.7. Poland 9.1.7.8. Rest of Europe 9.1.8. Europe Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel, and Country, 2019 – 2025 9.1.9. Europe Urothelial Carcinoma Treatment Market Dynamics – Trends 10. Asia-Pacific Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 10.1.1. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.2. Immunotherapy 10.1.3. Radiotherapy 10.1.4. Chemotherapy 10.1.5. Others 10.1.6. Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 10.1.6.1. Hospital Pharmacies 10.1.6.2. Retail Pharmacies 10.1.6.3. Others 10.1.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 10.1.7.1. Japan 10.1.7.2. China 10.1.7.3. India 10.1.7.4. ASEAN 10.1.7.5. Australia & New Zealand 10.1.7.6. Rest of Asia-Pacific 10.1.8. Asia-Pacific Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel, and Country, 2019 – 2025 10.1.9. Asia-Pacific Urothelial Carcinoma Treatment Market Dynamics – Trends 11. Latin America Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 11.1.1. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 11.1.2. Immunotherapy 11.1.3. Radiotherapy 11.1.4. Chemotherapy 11.1.5. Others 11.1.6. Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.6.1. Hospital Pharmacies 11.1.6.2. Retail Pharmacies 11.1.6.3. Others 11.1.7. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 11.1.7.1. Brazil 11.1.7.2. Mexico 11.1.7.3. Argentina 11.1.7.4. Venezuela 11.1.7.5. Rest of Latin America 11.1.8. Latin America Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel, and Country, 2019 – 2025 11.1.9. Latin America Urothelial Carcinoma Treatment Market Dynamics – Trends 12. Middle East and Africa Urothelial Carcinoma Treatment Market Analysis, 2014 - 2018 and Forecast, 2019 - 2025 12.1.1. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.2. Therapy Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.3. Immunotherapy 12.1.4. Radiotherapy 12.1.5. Chemotherapy 12.1.6. Others 12.1.7. Distribution Channel Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) 12.1.7.1. Hospital Pharmacies 12.1.7.2. Retail Pharmacies 12.1.7.3. Others 12.1.8. Country Analysis (2014 – 2018) and Forecast (2019 – 2025) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%) 12.1.8.1. Gulf Cooperation Council (GCC) Countries 12.1.8.2. Israel 12.1.8.3. South Africa 12.1.8.4. Rest of MEA 12.1.9. MEA Urothelial Carcinoma Treatment Market - Opportunity Analysis Index, By Therapy, Distribution Channel, and Country, 2019 – 2025 12.1.10. MEA Urothelial Carcinoma Treatment Market Dynamics – Trends 13. Competition Landscape 13.1. Strategic Dashboard of Top Market Players 13.2. Company Profiles (Introduction, Financial Analysis, Product & Service Offerings, Key Developments, Strategies, and SWOT Analysis) 13.2.1. Ferring B.V. (Switzerland) 13.2.2. Azanta A/S (Denmark) 13.2.3. Novartis AG (Switzerland) 13.2.4. GlaxoSmithKline plc (U.K.) 13.2.5. AstraZeneca plc (U.K.) 13.2.6. Pfizer, Inc. (U.S.) 13.2.7. Bayer AG (Germany) 14. Research Methodology 15. Key Assumptions and Acronyms
It is a well-organized procedure to carry out research. We at Market Growth Insight follow global, all-inclusive & iterative research methodology to develop our research reports. We are using both the top down as well as bottom-up approaches for partitioning and evaluating the significant aspects of the market.
It is a systematic & strategic approach for conducting a market study. Our market research methodology is based on the concept that gives a detailed description of the factors behind an observation. Let us see the detailed market research methodology.
It is the very basic stage of research the raw data is obtained and collected on a boarded front.Data is constantly filtered to ensure that only validated and authenticated sources are considered. Moreover,information is also mined from a large group of reports in our vault, as well as various reputed paid databases. It is necessary to understand the entire value chain and in order to facilitate this; we gather information from raw material suppliers, distributors as well as buyers, for extensive knowledge of the market.
The technical issues and trends are acquired from reviews, technical discussion and trade journals. Moreover, the technical data is also accumulated from intellectual property prospective, focusing on a void area and freedom of movement. The industry elements regarding drivers, restraints, pricing trends are also collected. Subsequently, the material developed contains a wide range of original and unique information that is then further cross-validated and authenticated with published sources.
Simulation models are responsible to estimate and forecast our market, and for each research, a unique model is created and customized. The data accumulated for market dynamics, innovation scene, application improvement, estimating trends is delivered into the model and analyzedsimultaneously. These components are examined on a comparative basis, and their impact on the figure of the frame is measured with the assistance of correlation, regression and time series investigation. Forecasting of the market is performed through the consolidation of economic tools, innovative examination, and industry experience along with domain expertise. Generally, economic models are utilized for short-termforecasting, technological market models are used for long-term forecasting of a market. These are based on an amalgamation of technology innovation, regulatory frameworks, economic outlook, and business principles. A bottom-up approach to the market estimation is preferred, with key regional markets analyzed as separate entities and integration of information to get a worldwide evaluation. This is very critical for a deep knowledge of the business as well as ensuring negligible mistakes. Below mentioned are some of the parameters are considered for forecasting
Market drivers and restraints, along with their current and expected impact
Raw material scenario and supply v/s price trends
Regulatory situation and expected developments
Current capacity and expected capacity additions up to 2025
Market driving organizations
To approve our information as far as exactness and adequacy
To pick up an understanding of the present market and future desires
We dole out weights to these parameters and evaluate their market effect utilizing weighted normal examination, to infer a normal market development rate.
This is the last advance in assessing and anticipating for our reports. Thorough essential meetings are led, on up close and personal and additionally via telephone to approve our discoveries and suppositions used to get them. Interviewees are drawn closer from driving organizations over the esteem chain including providers, innovation suppliers, area specialists,and purchasers in order to guarantee an all-encompassing and fair photo of the market. Essential meetings help in information approval, as well as give basic bits of knowledge into the market, current business situation and future desires and upgrade the nature of our reports. Every one of our assessments and figure is checked through comprehensive essential research with Key Industry Participants (KIPs) which ordinarily include:
This is the closing phase in estimating and forecasting for our reports. In this stage face to face and telephonic exhaustive interviews are conducted to validate our conclusion and assumptions used to obtain the final data. The leading companies across the value chain including suppliers, technology providers, domain experts,and purchasers are approaching the interviewees to ensure a holistic and unbiased view of the market. These interviews are led over the world, with language boundaries defeat with the guide of local staff and translators. Primary interviews in information validation as well as give critical insights into the market, current business outline and future expectations upgrade the quality of our reports. All our estimates and forecast are verified through exhaustive primary research with Key Industry Participants include
Leading market organizations
Raw material suppliers
Product dealer
Clients or Consumers
The key targets of primary research are as per the following:
To validate our data as far as exactness and adequacy
To pick up an understanding into the present market and future desires
Get from one of the finest selection of Market Research Reports.
Your payment is 100% secured with us ensuring a fair purchase.
We provide accurate research data with comparatively best prices in the market.
More than the finest 500 companies buy their research from us.
We provide responsive 24 hours a day and 365 days customer support.
The Customer Engagement Solutions market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based
Published - Feb 2020 I Price - from $2960
The Cell Sorter market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based on the Cell Sorte
Published - Feb 2020 I Price - from $2960
The Pertussis Vaccine market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based on the Pert
Published - Feb 2020 I Price - from $2960
The Vincristine For Injection market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based on
Published - Feb 2020 I Price - from $2960
The Dermal Facial Fillers market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based on the
Published - Feb 2020 I Price - from $2960
The Petri Dishes market revenue was xx.xx Million USD in 2015, grew to xx.xx Million USD in 2020, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025. Based on the Petri Dis
Published - Feb 2020 I Price - from $2960